Assenagon Asset Management S.A. Vanda Pharmaceuticals Inc. Transaction History
Assenagon Asset Management S.A.
- $37.1 Billion
- Q1 2024
A detailed history of Assenagon Asset Management S.A. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 730,820 shares of VNDA stock, worth $3.73 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
730,820
Previous 1,587,717
53.97%
Holding current value
$3.73 Million
Previous $6.7 Million
55.18%
% of portfolio
0.01%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding VNDA
# of Institutions
147Shares Held
49.6MCall Options Held
49.1KPut Options Held
107K-
Black Rock Inc. New York, NY8.14MShares$41.6 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.28MShares$21.8 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$17.4 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.37MShares$12.1 Million0.03% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.8MShares$9.21 Million0.01% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $289M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...